BRIEF-Benitec Biopharma gets orphan drug designation in EU for BB-301
* Receives orphan drug designation in European Union for BB-301 Source text for Eikon: Further company coverage:
Dec 21 Cyxone AB :
* Buys patent family to protect its T20K main candidate, for 100,930 euros ($105,189.25) including VAT
* Aims to complete the transaction with Medical University of Vienna in Q1 2017 Source text for Eikon: Further company coverage: ($1 = 0.9595 euros) (Gdynia Newsroom)
* Says it gets insurance regulator's approval to set up life insurance firm with partners
LONDON, Jan 17 People recovering from depression but struggling with its effect on memory, concentration and cognitive function may benefit from the stimulant modafinil, according to results of a small study published on Tuesday.